Alliance A082402

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
Protocol A082402, “Involved-Station, Intensity-Modulated Post-Operative Radiation Therapy (I²-Port) for Resected Non-Small Cell Lung Cancer with Residual Mediastinal Adenopathy after Neoadjuvant Therapy (ypn2))
Principal Investigator
Headshot of Trey Carlton Mullikin
Assistant Professor of Radiation Oncology
Protocol Number
IRB: PRO00121091
NCT: NCT07293247
Phase
Phase II
ClinicalTrials.gov
Status
OPEN TO ACCRUAL
Participate